These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populations. Goldstein M; Fuxe K; Meller E; Seyfried CA; Agnati L; Mascagni FM J Neural Transm; 1987; 70(3-4):193-215. PubMed ID: 2890706 [TBL] [Abstract][Full Text] [Related]
4. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects. Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753 [TBL] [Abstract][Full Text] [Related]
5. Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system. Maj J; Kołodziejczyk K; Rogóz Z; Skuza G Pharmacopsychiatry; 1997 Mar; 30(2):55-61. PubMed ID: 9131725 [TBL] [Abstract][Full Text] [Related]
6. Interactions of trazodone with serotonin neurons and receptors. Fuller RW; Snoddy HD; Cohen ML Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of dopamine D2 receptors following long-term treatment with roxindole. Seyfried CA; Bartoszyk GD Eur J Pharmacol; 1994 May; 257(1-2):67-72. PubMed ID: 7915991 [TBL] [Abstract][Full Text] [Related]
9. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Meller E; Goldstein M; Bohmaker K Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223 [TBL] [Abstract][Full Text] [Related]
10. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949 [TBL] [Abstract][Full Text] [Related]
11. Mixed agonist-antagonist properties of umespirone at neostriatal dopamine receptors in relation to its behavioral effects in the rat. Ahlenius S; Wijkström A Eur J Pharmacol; 1992 Nov; 222(1):69-74. PubMed ID: 1361441 [TBL] [Abstract][Full Text] [Related]
12. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain? Dugast C; Soulière F; Schmitt P; Casanovas JM; Fattaccini CM; Mocaër E; Lesourd M; Renaud B; Artigas F; Hamon M; Chouvet G Eur J Pharmacol; 1998 Jun; 350(2-3):171-80. PubMed ID: 9696405 [TBL] [Abstract][Full Text] [Related]
13. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. Enz A; Goldstein M; Meller E Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116 [TBL] [Abstract][Full Text] [Related]
14. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus. Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794 [TBL] [Abstract][Full Text] [Related]
15. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Johnson MP; Conarty PF; Nichols DE Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125 [TBL] [Abstract][Full Text] [Related]
16. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. Hjorth S; Pettersson G Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622 [TBL] [Abstract][Full Text] [Related]
17. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155 [TBL] [Abstract][Full Text] [Related]
19. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761 [TBL] [Abstract][Full Text] [Related]
20. Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]